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Understanding where the greatest risk to a herd 
is relative to the introduction of bovine viral diarrhea 
(BVD) virus, is paramount to controlling or preventing 
economic losses to BVD. One of the first steps in the 
risk assessment process is determining if BVDv is 
present in the herd.  
The virus can be present in the herd as transient 
infections or through persistently-infected animals. 
Transient infections are those acute viral episodes that 
infects the animal, to which the animal then mounts an 
immune response which often eliminates the disease 
from the animal following a period of reduced 
productivity due to the fact that the animal’s immune 
system is trying to eliminate the virus. These infections 
can be spread from animal to animal depending on herd 
immunity.  
Persistant infections, on the other hand, are 
caused by animals who are infected with disease in 
utero. When exposed during the critical window of time 
between the second and fifth month of gestation, the 
naïve fetal immune system may not recognize the virus 
as foreign. In this scenerio the virus is identified by the 
immune system as “self” or “normal” and thus the fetus 
and subsequent calf becomes persistently infected (PI). 
These PI animals shed the virus when born in 
remarkable amounts. While transient infections are most 
commonly found in herds, PI animals can add 
significantly to a herd’s viral load when present. 
The first box of Figure 1 ranks the cost and 
reliability of different techniques used to determine if the 
virus is circulating within the herd; ranked from least 
reliable (top) to most reliable (bottom). For example, the 
observation for clincial signs is much less costly and 
reliable than submiting biological (i.e, ear) samples for 
testing.  
If BVDv is circulating in the herd the main 
objective becomes biocontainment. Biocontainment is 
simply defined as processes and procedures 
implemented to prevent further exposure or risk from a 
known disease or issue. With BVDv, the second box of 
Figure 1 illustrates two objectives to consider in 
biocontainment. These include minimizing the negative 
impact of infection and the elimination of circulating 
virus within the herd. 
Vaccination and testing are critical components 
in biocontainment as it relates to BVD. The overall 
objective with these two tools is to increase herd 
immunity through vaccination and to identify PI’s 
through testing. There are two different types of vaccines 
available for use against BVDv, they are commonly 
referred to as “killed” or “modified-live.” There are pros 
and cons to using either inactivated (killed) or attenuated 
(modified live) vaccine preparations. Table 1 dicusses 
the advantages and disadvantages of both.  
There are several methods used to diagnose the 
virus in the herd. Table 2 organizes these tests and 
discusses some of the limitations of each. The most 
common sample submitted is an ear notch, and the most 
common test preformed is antigen-capture ELISA 
(ACE). ACE testing of ear notches seems to be very 
reliable and has a relative low cost when compared to 
others. Ears are handy to sample from, but any skin 
sample will suffice.  
Vaccination timing plays a large role in 
minimizing risk. Figure 2 illustrates the most and least 
reliable vaccination schedules and timing to prevent 
disease in calves and heifers. It is recommneded that 
vaccinating calves early (4 months of age) and often 
(giving boosters) will increase their immunity and 
decrease the risk for disease (Figure 2). For heifers and 
cows, making sure that they are boostered with a 
modified live BVDv vaccine, 30 days prior to breeding 
is the more reliable management pracatice for preventing 











Bulls have been proven to transmit the disease 
both in semen and by direct contact. Do not forget to 
address disease mitigation in the bulls in the herd 
through development of a vaccine program for them that 
best reduces risk (Figure 2). The best recommendation 
includes the use of a cytopathic modified live virus in 
bulls. Bulls vaccinated with non-cyctopathic vaccine 
have shed virus in their semen. Most U.S. common 
modified live BVDv vaccines contain only cyctopathic 
strains of BVDv. 
If virus is not circulating in the herd, then 
biosecurity becomes very important in minimizing the 
risk for introduction of the virus. Figure 1 suggests the 
most reliable management practices for reducing the risk 
of BVDv introduction. Initiating all of the 
recommendations of biosecurity in Figure 1 should 
reduce or eliminate most of the risk. Testing all 
replacement animals and implementing a strict 21-day 
quarantine is the most reliable way to minimize risk. 
This suggestion may also be the most restrictive.  
This information is intended to be used as a 
reference from which to start the conversation for 
establishing management procedures to prevent loss 
from BVDv. In summary, understanding the risk for 
BVDv to your herd is critical to preventing, controlling, 
or eradicating the disease. The first step is to determine 
if the virus is already present in the herd. There are more 
reliable methods to help you determine if BVDv is 
present, with targeted testing being the most reliable and 
most costly (Figure 1). Depending on the answer to the 
question, “Is BVDv present?” you will either want to 
consider implementing principles of biocontainment 
(virus present) or biosecurity (virus not present) (Figure 
1). Vaccination can be a good tool in minimizing the 
impact of BVDv in the herd or to be used in helping to 
prevent the development of PI animals. In general, using 
a modified-live virus preparation early and often 
(including 30 days prior to breeding in heifers) is the 
most reliable way to prevent PI animals (Figure 2). 
Remember, there are considerations to be aware of when 
choosing between the two types of vaccines (Table 1).  
For further information concerning the 
prevalence of BVDv in your area, and for help in 
designing a vaccination/testing program for your herd, 
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